Prognosis and therapy of complex partial seizures with barbiturates, hydantoins, and other drugs.
D000927:Anticonvulsants / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D006827:Hydantoins / Q000627:therapeutic use*; D008617:Mephenytoin / Q000627:therapeutic use; D010634:Phenobarbital / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011324:Primidone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D013388:Succinimides / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D001463:Barbiturates; D006827:Hydantoins; D013388:Succinimides; D013843:Thiazines; D001569:Benzodiazepines; D011324:Primidone; D014635:Valproic Acid; D010672:Phenytoin; D008617:Mephenytoin; D010634:Phenobarbital